Skip to Main Content

Paper Details

Longitudinal serum biomarker screening identifies malate dehydrogenase 2 as candidate prognostic biomarker for Duchenne muscular dystrophy.
J Cachexia Sarcopenia Muscle
23
2020
Author NameAffiliation
Burcu AyogluKTH Royal Institute of Technology
Hanns Lochm??llerMedical Center, University of Freiburg
Hanns Lochm??llerCenter for Genomic Regulation, Barcelona Institute of Science and Technology (BIST)
Hanns Lochm??llerChildren's Hospital of Eastern Ontario Research Institute, University of Ottawa
Hanns Lochm??llerThe Ottawa Hospital
Volker StraubInstitute of Genetic Medicine, Newcastle University
Francesco MuntoniUCL Institute of Child Health
Anja PerssonKTH Royal Institute of Technology
Peter NilssonKTH Royal Institute of Technology
Cristina Al-Khalili SzigyartoKTH Royal Institute of Technology
Cristina Al-Khalili SzigyartoKTH Royal Institute of Technology
  • 1 - 11

Datasets

Release 1.2